Literature DB >> 10837505

Further evidence for a dissociation between different forms of mnemonic expressions in a mouse model of age-related cognitive decline: effects of tacrine and S 17092, a novel prolyl endopeptidase inhibitor.

A Marighetto1, K Touzani, N Etchamendy, C C Torrea, G De Nanteuil, D Guez, R Jaffard, P Morain.   

Abstract

It has been demonstrated previously on the radial maze that the emergence of an age-related mnemonic impairment is critically dependent on the form which the discrimination problems took. Hence, when the arms were presented one by one (i.e., successive go-no-go discrimination), both adult and aged mice learned to distinguish between positive (baited) and negative (unbaited) arms readily, as evidenced by their increased readiness to enter positive relative to negative arms (i.e., by a differential in arm-entry latencies). A selective impairment in the aged mice was seen when these arms were presented subsequently as pairs, such that the mice were confronted with an explicit choice (i.e., simultaneous 2-choice discrimination). When discriminative performance was measured by the differential run speed between positive and negative arms, aged mice were also impaired. This was particularly pronounced in the 2-choice discrimination condition. We examined the effects of tacrine (3mg/kg, subcutaneously) or S 17092 (10mg/kg, orally) in aged mice on the three behavioral indices of this 2-stage spatial discrimination paradigm. The results indicated that: (1) Tacrine, but not S 17092, enhanced the acquisition of go-no-go discrimination as reflected in arm-entry latencies; (2) both drugs improved choice accuracy in simultaneous discrimination, although the effect of tacrine was less striking and, in particular, far from statistical significance in the very first 2-choice responses; and (3) neither drugs significantly affected run-speed performance. We conclude further that the specific patterns of drug effects on the three indices of discriminative performance might suggest that each index is associated with a distinct form of mnemonic expression relying on separate neural systems.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837505      PMCID: PMC311328          DOI: 10.1101/lm.7.3.159

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  40 in total

1.  Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P 1-11.

Authors:  R Mattioli; R K Schwarting; J P Huston
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

Review 2.  Neuropeptides and Alzheimer's disease.

Authors:  M M Husain; C B Nemeroff
Journal:  J Am Geriatr Soc       Date:  1990-08       Impact factor: 5.562

3.  Effects of cholinesterase inhibitors on learning and memory in rats: a brief review with special reference to THA.

Authors:  A H Mohammed
Journal:  Acta Neurol Scand Suppl       Date:  1993

4.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

Review 5.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

6.  Knowing which and knowing what: a potential mouse model for age-related human declarative memory decline.

Authors:  A Marighetto; N Etchamendy; K Touzani; C C Torrea; B K Yee; J N Rawlins; R Jaffard
Journal:  Eur J Neurosci       Date:  1999-09       Impact factor: 3.386

7.  Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis.

Authors:  M G Giovannini; F Casamenti; A Nistri; F Paoli; G Pepeu
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

8.  Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats.

Authors:  P Riekkinen; J Sirviö; M Riekkinen; P Riekkinen
Journal:  Pharmacol Biochem Behav       Date:  1991-08       Impact factor: 3.533

9.  Neurotrophic effects of substance P on hippocampal neurons in vitro.

Authors:  C J Whitty; G Kapatos; M J Bannon
Journal:  Neurosci Lett       Date:  1993-12-24       Impact factor: 3.046

Review 10.  Prolyl endopeptidase.

Authors:  S Wilk
Journal:  Life Sci       Date:  1983-11-28       Impact factor: 5.037

View more
  6 in total

1.  Alleviation of a selective age-related relational memory deficit in mice by pharmacologically induced normalization of brain retinoid signaling.

Authors:  N Etchamendy; V Enderlin; A Marighetto; R M Vouimba; V Pallet; R Jaffard; P Higueret
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

Review 2.  Peptidomics of the prolyl peptidases.

Authors:  Anna Mari Lone; Whitney M Nolte; Arthur D Tinoco; Alan Saghatelian
Journal:  AAPS J       Date:  2010-06-16       Impact factor: 4.009

3.  The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.

Authors:  Mari H Savolainen; Christopher T Richie; Brandon K Harvey; Pekka T Männistö; Kathleen A Maguire-Zeiss; Timo T Myöhänen
Journal:  Neurobiol Dis       Date:  2014-04-16       Impact factor: 5.996

4.  Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site.

Authors:  Jarkko I Venäläinen; Risto O Juvonen; J Arturo Garcia-Horsman; Erik A A Wallén; Johannes A M Christiaans; Elina M Jarho; Jukka Gynther; Pekka T Männistö
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

Review 5.  Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies.

Authors:  Uros V Djekic; Amit Gaggar; Nathaniel M Weathington
Journal:  Pharmacol Ther       Date:  2008-10-31       Impact factor: 12.310

6.  Comparative effects of the alpha7 nicotinic partial agonist, S 24795, and the cholinesterase inhibitor, donepezil, against aging-related deficits in declarative and working memory in mice.

Authors:  A Marighetto; S Valerio; A Desmedt; J N Philippin; C Trocmé-Thibierge; P Morain
Journal:  Psychopharmacology (Berl)       Date:  2008-02-12       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.